KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Kairos Pharma, LTD.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.57−0.03 (-5.19%)
Close on Oct 19, 2026
- Market cap
- $12.21M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$5.57MFY2025